3O PRODIGE 68 - UCGI 38 - SOREGATT: A randomized phase II study comparing the sequences of regorafenib (reg) and trifluridine/tipiracil (t/t) after failure of standard therapies in patients (pts) with metastatic colorectal cancer (mCRC)

Authors:
  • MDM.P. Ducreux
    M.P. Ducreux
  • MAM. Ben Abdelghani
    M. Ben Abdelghani
  • DTD. Tougeron
    D. Tougeron
  • OBO. Bouche
    O. Bouche
  • JVJ. Viaud
    J. Viaud
  • FAF. Khemissa Akouz
    F. Khemissa Akouz
  • JMJ. Martin-Babau
    J. Martin-Babau
  • JBJ-B. Bachet
    J-B. Bachet
  • CCC. Coutzac
    C. Coutzac
  • HCH. Castanie
    H. Castanie
  • JTJ. Taieb
    J. Taieb
  • JPJ.M. Phelip
    J.M. Phelip

Abstract
No abstract available